NEW FAB D

PROBLEM TO BE SOLVED: To provide a factor that can be used for assaying the role of an antibiotic substance in the pathology of infection, dysfunction, and development of disease by screening antibiotic activity. SOLUTION: This factor is an isolated polynucleotide having a member selected from the g...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LONSDALE JOHN TIMOTHY, PAYNE DAVID JOHN, GENTRY DANIEL ROBERT, PEARSON STEWART C
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide a factor that can be used for assaying the role of an antibiotic substance in the pathology of infection, dysfunction, and development of disease by screening antibiotic activity. SOLUTION: This factor is an isolated polynucleotide having a member selected from the group consisting of (a) a polynucleotide having a homology at 70% or more to the polynucleotide having a specific sequence derived from Staphylococcus aureus, (b) a polynucleotide complementary to the polynucleotide (a), and (c) a polynucleotide having fifteen serial bases or more of the polynucleotide (a) or (b).